Rob Neville


Mr. Neville is one of the founders of Savara and has served as CEO and President since 2008. Prior to Savara, Mr. Neville was founder and CEO of Evity, Inc., which was acquired by BMC in 2000. Based on his work at Evity and Savara, Mr. Neville was honored as a two-time finalist for the Ernst & Young Entrepreneur of the Year award. As managing director of Clockwise Consulting, he partnered with the Texas Children’s Hospital and the Baylor College of Medicine to develop ICU-based monitoring and diagnostic devices. Mr. Neville holds a post-graduate Engineering degree from the University of Natal South Africa.

Taneli Jouhikainen


Dr. Jouhikainen (MD, PhD, MBA) is one of the founders of Savara and serves as Chief Operating Officer. During his career as a veteran medical executive, Dr. Jouhikainen has held executive positions with several companies including Interim CEO and Senior Vice President of Product Development at Akela Pharma Inc., President and CEO at Focus Inhalation, Chairman of the Board at Spectrum Medical Sciences, and Director of Clinical Research at Leiras/Schering AG.

Cecilia Ganslandt

Head of Medical Affairs

Ms. Cecilia Ganslandt (MD, MSc Pharmaceutical Medicine) serves as Head of Medical Affairs and has more than 19 years of experience from positions within global clinical development and medical affairs in small, mid-size and large pharma companies. She has supported a number of clinical development programs from early clinical phase up to and beyond marketing authorizations in Europe, US and Asia. Prior to joining Savara, she was CMO for Serendex Pharmaceuticals, assuming overall responsibility for nonclinical and clinical development.

John Lord

Head of CMC

Dr. Lord (PhD) serves as Head of Pharmaceutical Development and is responsible for all CMC activities. He has over 22 years of inhalation product development experience including leadership roles at pharmaceutical companies like Rhône-Poulenc Rorer and Nektar Therapeutics. He has experience across multiple inhalation formulation and device technologies including dry-powder inhalers, pressurized metered dose inhalers and nebulizers.

Chris Marich

Head of Business Operations

Mr. Marich (MBA) is one of the founders of Savara and serves as Head of Business Operations. He has significant experience managing the financial and logistical components of large multi-team projects across numerous industries including enterprise software and pharmaceutical product development. Mr. Marich has co-founded numerous companies from inception to exit and specializes in business strategy, corporate structures, fundraising, and project management.

Kenny Frazier

Head of Clinical Development

Mr. Frazier (BSc.) serves as Head of Clinical Development and has more than 25 years of experience in clinical development including twenty years in biotech and large pharma. He has extensive experience managing operational activities of early (FIH) development programs through late-stage phase 3 clinical trials across a number of therapeutic areas. Prior to joining Savara, Mr. Frazier served as the Head of Clinical Development and Regulatory Affairs for Opexa Therapeutics.

Mette Vinge

Head of Regulatory Affairs

Ms. Vinge serves as Head of Regulatory Affairs and is responsible for all regulatory activities. She has more than 14 years of experience in regulatory affairs focusing on biopharmaceutical products within rare diseases. She has successfully driven the regulatory development strategy and registration activities for several projects at pharmaceutical companies like Pfizer, Takeda and Serendex. Ms. Vinge holds a Master of Pharmaceutical Science from University of Copenhagen and a Diploma of Pharmaceutical Regulatory Affairs.

Inge Tarnow

Head of Nonclinical Development

Dr. Tarnow serves as Head of Nonclinical Development and has more than 15 years of experience from biotech and mid-size pharma companies and from academia. She has experience in managing bioanalytical programs, clinical development projects from early phase to Phase III and extensive laboratory research experience. Dr. Tarnow is Doctor of Veterinary Medicine and holds a PhD in pathophysiology from University of Copenhagen. Her latest position in academia was Professor of Veterinary Clinical Pathology and prior to joining Savara, she served as Medical Manager in Serendex.

Luke Lawson

Head of Quality

Dr. Lawson serves as Senior Director of Quality at Savara and has more than 20 years of experience serving regulated industries in engineering, project management, process validation, regulatory and quality operations capacities. Dr. Lawson is responsible for the oversight of Clinical Quality and GMP Manufacturing Operations including batch release, quality investigations, validation, quality training, and management of internal/external inspections. Dr. Lawson holds a B.S. in Chemistry from Tarleton State University and a Ph.D. in Chemical Engineering from Columbia.

Back to Top